---
source_pdf: "Google Drive/Research/Slope Seed Pitch Deck - Q4 2019.pdf"
type: pitch-deck
company: Slope
date: Q4 2019
ingested: 2025-12-26
---

# Slope - Seed Pitch Deck (Q4 2019)

**Data-driven clinical trial supply chain management.**

Rust Felix - Co-Founder & CEO

## Problem

**94% of clinical trials are delayed more than a month. Delays cost $600K to $8M per day.**

Trial Sponsors lose hundreds of millions of dollars because their supply chains are too complex for people to manage:

- **Trial Vendors:** Drug, device, kit, and supply distribution is reactive
- **Research Sites:** No systems exist to help sites manage inventory & orders
- **Study Patients:** No easy way to forecast patient inventory requirements
- **Analytical Labs:** Ensuring samples end up at the right labs requires lots of PM

## Solution

First connected clinical supply chain management platform that ensures everyone knows where everything is.

**Before Slope:** Inaccurate forecasts cause study delays
- Sponsors, CROs, and Vendors don't have visibility into clinical inventory usage at trial sites
- Spreadsheet models and simulations relied on for demand forecasting and PM
- Site demand isn't balanced with vendor supply

**With Slope:** Data powers supply chain automation
- Sites use Slope to manage their inventory
- ClinOps teams connected to data in real-time
- Vendors improve distribution accuracy with better inventory mgmt

## Traction (Q4 2019)

- **$2.6M TCV** of clinical trials launched Q4 2019
- **$4M+ TCV** of trials launching in 2020
- **~$9M TCV** in deployments scheduled for next 18-24 months
- 7 paid clinical trials with channel partners
- 875 clinical stakeholders using platform

**Analytics:**
- 135K+ Clinical Inventory & Assets Managed
- 2.1K+ Clinical Trials Managed
- 276 Research Sites Using Platform
- 33% Oncology Focused Clinical Trials

## Market

- **TAM:** $19.1B (Global trial supplies and logistics)
- **SAM:** $5.5B (29% of active trials are oncology - ~25k trial count)
- **SOM:** $28M (5% of oncology trials, 10% early adopter capture)

## Business Model

| Segment | Model | TCV |
|---------|-------|-----|
| Research Sites | Free (network growth) | - |
| Sponsors & CROs | SaaS per trial + setup fees | ~$500k+ per trial |
| Vendor Channel Partners | Monthly SaaS + revenue share | ~$25k-$50k per trial |

## Competitive Landscape

Slope's site-centric data collection model and focus on more than just drugs sets it apart.

Competitors: TrakCel, Vineti (not clinical trial specific), 4G Clinical, Endpoint, Signant Health (drug-only solutions), PATH-TEC, ALMAC (walled garden)

## The Ask

**Raising $3M in Seed Financing**

- Previous $1.2M raise lasted 30+ months
- Combined pipelines expected to generate $3M ARR by December 2020
- Headcount: 5 â†’ 12
- $2M staffing budget for 24+ months
- $300K marketing/conferences over 24 months

## Team

- **Rust Felix** - Co-Founder & CEO (Amazon predictive forecasting, Google/NSA data center tech)
- **Michael Felix** - Co-Founder & CTO (Supply chain platform designer, former SCAD professor)
- **Scott Endicott** - VP, Client Services ($90M+ lifetime pharma sales, 20+ years clinical logistics)
- **Joy Jurnack, RN** - Dir. Site Engagement (35+ year clinical research nurse)
- **Enrique Gomez** - Industry Advisor (20+ years global clinical supply chains, Top 20 Pharma)
- **Dan Hargrove** - Industry Advisor (Co-Founder Cancer Insight CRO)
